HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis.

AbstractOBJECTIVE:
To examine the association of serum inflammatory markers (erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)) and serum lipid measures (low-density lipoprotein (LDL)- and high-density lipoprotein (HDL)-cholesterol) with risk of myocardial infarction (MI) and ischaemic stroke (IS) among rheumatoid arthritis (RA) patients.
METHODS:
We conducted a retrospective cohort study using 2005-2010 data from a US commercial health plan. Eligible patients had two or more physician diagnoses of RA during a baseline period of at least 180 days with continuous medical and pharmacy coverage. We computed age-adjusted incidence rates of MI and IS, and used spline regression to assess non-linear associations and Cox-regression to quantify the independent association between the laboratory values and the outcomes.
RESULTS:
We identified 44 418 eligible RA patients (mean age 49 years; 76% women). CRP>10 mg/L compared with <1 mg/L was associated with increased MI risk (HR 2.12; 95% CI 1.02 to 4.38). ESR>42 mm/h compared with <14 mm/h was associated with increased risk of MI (HR 2.53; 95% CI 1.48 to 4.31) and IS (HR 2.51; 95% CI 1.33 to 4.75) risk. HDL-cholesterol ≥60 mg/dL (1.6 mmol/L) compared with <40 mg/dL (1.0 mmol/L) was associated with reduced MI risk (HR 0.37; 0.21 to 0.66). The association between LDL and MI was not linear; the lowest risk was observed among patients with LDL between 70 mg/L (1.8 mmol/L) and 100 mg/L (2.6 mmol/L). We did not observe a significant association between LDL and IS.
CONCLUSIONS:
This study provides evidence supporting the hypothesis that RA-related systemic inflammation plays a role in determining cardiovascular risk and a complex relationship between LDL and cardiovascular risk.
AuthorsJie Zhang, Lang Chen, Elizabeth Delzell, Paul Muntner, William B Hillegass, Monika M Safford, Iris Yolanda Navarro Millan, Cynthia S Crowson, Jeffrey R Curtis
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 73 Issue 7 Pg. 1301-8 (Jul 2014) ISSN: 1468-2060 [Electronic] England
PMID24796336 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightPublished by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Chemical References
  • Biomarkers
  • Cholesterol, HDL
  • Cholesterol, LDL
  • C-Reactive Protein
Topics
  • Adult
  • Arthritis, Rheumatoid (blood, complications, metabolism)
  • Biomarkers (blood, metabolism)
  • Blood Sedimentation
  • Brain Ischemia (blood, complications, metabolism)
  • C-Reactive Protein (metabolism)
  • Cholesterol, HDL (blood)
  • Cholesterol, LDL (blood)
  • Cohort Studies
  • Female
  • Humans
  • Inflammation (blood, complications, metabolism)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Myocardial Infarction (blood, complications, metabolism)
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk Factors
  • Stroke (blood, etiology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: